NewEdge Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.7M | Sell |
93,040
-2,899
| -3% | -$992K | 0.1% | 204 |
|
|
2026
Q1 | $33.8M | Sell |
95,939
-2,821
| -3% | -$1.01M | 0.12% | 169 |
|
|
2025
Q4 | $32.3M | Buy |
98,760
+9,992
| +11% | +$3.17M | 0.12% | 170 |
|
|
2025
Q3 | $25.1M | Buy |
88,768
+9,344
| +12% | +$2.71M | 0.11% | 173 |
|
|
2025
Q2 | $22.2M | Buy |
79,424
+3,640
| +5% | +$1.03M | 0.11% | 181 |
|
|
2025
Q1 | $23.6M | Buy |
75,784
+6,685
| +10% | +$1.97M | 0.14% | 151 |
|
|
2024
Q4 | $18M | Buy |
69,099
+3,786
| +6% | +$1.12M | 0.11% | 188 |
|
|
2024
Q3 | $21M | Buy |
65,313
+1,504
| +2% | +$492K | 0.14% | 161 |
|
|
2024
Q2 | $19.9M | Buy |
63,809
+13,542
| +27% | +$3.98M | 0.15% | 142 |
|
|
2024
Q1 | $14.3M | Sell |
50,267
-195
| -0.4% | -$57.1K | 0.12% | 171 |
|
|
2023
Q4 | $15M | Buy |
50,462
+6,980
| +16% | +$1.9M | 0.14% | 155 |
|
|
2023
Q3 | $11.7M | Sell |
43,482
-3,681
| -8% | -$919K | 0.13% | 164 |
|
|
2023
Q2 | $10.5M | Buy |
47,163
+3,888
| +9% | +$902K | 0.12% | 178 |
|
|
2023
Q1 | $10.4M | Sell |
43,275
-2,057
| -5% | -$505K | 0.13% | 166 |
|
|
2022
Q4 | $4.6M | Buy |
45,332
+13,776
| +44% | +$3.69M | 0.12% | 179 |
|
|
2022
Q3 | $7.11M | Buy |
31,556
+4,893
| +18% | +$1.19M | 0.12% | 186 |
|
|
2022
Q2 | $6.49M | Sell |
26,663
-1,383
| -5% | -$339K | 0.11% | 189 |
|
|
2022
Q1 | $6.78M | Sell |
28,046
-389
| -1% | -$89.4K | 0.11% | 188 |
|
|
2021
Q4 | $6.4M | Buy |
28,435
+15,865
| +126% | +$3.35M | 0.1% | 206 |
|
|
2021
Q3 | $2.67M | Sell |
12,570
-1,769
| -12% | -$407K | 0.07% | 263 |
|
|
2021
Q2 | $3.5M | Sell |
14,339
-3,339
| -19% | -$821K | 0.09% | 212 |
|
|
2021
Q1 | $4.4M | Sell |
17,678
-3,679
| -17% | -$878K | 0.13% | 169 |
|
|
2020
Q4 | $4.91M | Sell |
21,357
-11,770
| -36% | -$2.71M | 0.16% | 133 |
|
|
2020
Q3 | $8.42M | Buy |
33,127
+8,998
| +37% | +$2.23M | 0.29% | 86 |
|
|
2020
Q2 | $5.69M | Buy |
24,129
+1,413
| +6% | +$322K | 0.22% | 103 |
|
|
2020
Q1 | $4.61M | Buy |
22,716
+5,458
| +32% | +$1.19M | 0.22% | 108 |
|
|
2019
Q4 | $4.16M | Buy |
17,258
+5,740
| +50% | +$1.27M | 0.17% | 141 |
|
|
2019
Q3 | $2.23M | Buy |
11,518
+2,032
| +21% | +$390K | 0.1% | 200 |
|
|
2019
Q2 | $1.75M | Sell |
9,486
-54,868
| -85% | -$9.82M | 0.11% | 194 |
|
|
2019
Q1 | $12.2M | Buy |
64,354
+13,978
| +28% | +$2.67M | 0.79% | 31 |
|
|
2018
Q4 | $9.81M | Buy |
50,376
+44,946
| +828% | +$8.77M | 0.63% | 34 |
|
|
2018
Q3 | $1.13M | Sell |
5,430
-254
| -4% | -$50.1K | 0.09% | 216 |
|
|
2018
Q2 | $1.05M | Sell |
5,684
-657
| -10% | -$116K | 0.1% | 204 |
|
|
2018
Q1 | $1.05M | Sell |
6,341
-4,847
| -43% | -$890K | 0.12% | 181 |
|
|
2017
Q4 | $2.02M | Sell |
11,188
-929
| -8% | -$164K | 0.27% | 81 |
|
|
2017
Q3 | $2.25M | Buy |
12,117
+1,309
| +12% | +$232K | 0.35% | 75 |
|
|
2017
Q2 | $1.86M | Buy |
10,808
+978
| +10% | +$159K | 0.32% | 73 |
|
|
2017
Q1 | $1.59M | Buy |
9,830
+7,097
| +260% | +$1.18M | 0.36% | 71 |
|
|
2016
Q4 | $429K | Buy |
+2,733
| New | +$411K | 0.12% | 159 |
|
Other funds holding AMGN
NewEdge Advisors's AMGN Position: Q2 2026 in Review
NewEdge Advisors reduced its Amgen (AMGN) stake by 3% in Q2 2026, selling an estimated $992K and leaving 93,040 shares worth $33.7M. The position accounts for 0.1% of the portfolio, ranked #204.
NewEdge Advisors first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $33.8M in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- NewEdge Advisors held 93,040 shares of Amgen worth $33.7M as of Q2 2026.
- NewEdge Advisors sold 2,899 Amgen shares in Q2 2026, an estimated $992K.
- Amgen made up 0.1% of NewEdge Advisors's portfolio in Q2 2026, its #204 holding.
- NewEdge Advisors first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
- NewEdge Advisors's Amgen position peaked at $33.8M in Q1 2026.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.